Studienergebnisse DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies 23.12.2025 / 14:36 CET/CEST ...

South Korean biotech company secures US$8 million in upfront payment for the joint commercialization of the stem cell therapy CARTISTEM® targeting the Japanes ...

Ribosomes—the tiny factories that build proteins in our cells—don't all work with the same efficiency. Researchers from Japan have discovered that ...

Researchers have identified the mechanism by which cancer cells create their own growth signals to proliferate, independent ...

Seattle — Dec. 18, 2025 — Fred Hutch Cancer Center researchers have developed a new tool that enables anyone to immediately assess their colorectal cancer risk online. Called MyGeneRisk, the free, web ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

Through a recent notice, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has ...

Research revealed how bacteriophages use a tiny piece of genetic material to hijack bacterial cells and make more copies of themselves.

Scientists have identified a natural human protein that can rouse dormant HIV inside infected cells, a finding that sharpens one of the most promising paths toward a cure. By showing that the virus’s ...

News » DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies ...

Gene Solutions, a pioneering genetic testing company, announced key achievements at the European Society for Medic ...

Keeping up with the world of biotech can feel like a full-time job, right? There’s always something new happening, from ...